N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof have been found to be effective as pharmaceutical agents for the inhibition and suppression of thrombosis.
Drawings
Claims8
N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides having the formula (I):
##STR40## and the pharmaceutically acceptable salts thereof, wherein R.sub.1 is naphthyl substituted with at least one C.sub.1 -C.sub.5 alkoxy;
R.sub.2 is selected from the group consisting of C.sub.2 -C.sub.10 alkyl, C.sub.2 -C.sub.10 alkoxyalkyl, C.sub.2 -C.sub.10 alkylthioalkyl, C.sub.7 -C.sub.15 aralkyl, C.sub.3 -C.sub.10 cycloalkyl and C.sub.4 -C.sub.10 cycloalkylalkyl;
R.sub.3 is C.sub.1 -C.sub.5 alkyl;
and R.sub.4 is selected from the group consisting of hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.7 -C.sub.12 aralkyl and C.sub.6 -C.sub.10 aryl.
1 more element
A method of inhibiting activity and suppressing activation of thrombin in vivo, which comprises administering to a patient a pharmaceutically effective amount of an N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamide having the formula (I):
##STR41## or the pharmaceutically acceptable salts thereof, wherein R.sub.1 is naphthyl substituted with at least one C.sub.1 -C.sub.5 alkoxy;
R.sub.2 is selected from the group consisting of C.sub.2 -C.sub.10 alkyl, C.sub.2 -C.sub.10 alkoxyalkyl, C.sub.2 -C.sub.10 alkylthioalkyl, C.sub.7 -C.sub.15 aralkyl, C.sub.3 -C.sub.10 cycloalkyl and C.sub.4 -C.sub.10 cycloalkylalkyl;
R.sub.3 is C.sub.1 -C.sub.5 alkyl;
and R.sub.4 is selected from the group consisting of hydrogen, C.sub.1 -C.sub.10 alkyl, C.sub.7 -C.sub.12 aralkyl and C.sub.6 -C.sub.10 aryl.
05/656,870Filed 10 Feb 1976 · continuation in part
Priority
14 Oct 1975
Granted
6 Sep 1977
Term ended
6 Sep 1994Estimated · howhidePre-1995 term; greater of 17 years from grant or 20 years from filing when eligible. Maintenance-fee lapses, terminal disclaimers and statutory extensions have not been checked. The continuity chain may be incomplete; this is not an enforceability determination.
#This invention relates to the discovery of certain new and useful N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides and the pharmaceutically acceptable salts thereof, which are of especial value in view of their outstanding antithrombotic properties and low toxicities.
#This invention relates to a group of N.sup.2 -alkoxynaphthalenesulfonyl-L-argininamides of the formula (I): ##STR2## wherein R.sub.1 is an alkoxynaphthyl wherein the alkoxy groups have 1-5 (preferably 1-3) carbon atoms, such as methoxy, ethoxy, propoxy, isopropoxy, butoxy, sec-butoxy, tert-butoxy, pentyloxy or the like. Preferred are those naphthyl groups having one or two alkoxy substituents, when two or more alkoxy groups are present, each may be the same or different; R.sub.2 is alkyl of 2-10 (preferably 2-6) carbon atoms, such as ethyl, propyl, butyl, isobutyl, pentyl, hexyl, octyl, decyl or the like, alkoxyalkyl of 2-10 (preferably 2-6) carbon atoms, such as methoxymethyl, ethoxymethyl, propoxymethyl, 2-methoxyethyl, 2-ethoxyethyl, 2-propoxyethyl, 3-methoxypropyl, 3-ethoxypropyl, 3-propoxypropyl, 4-methoxybutyl, 4-ethoxybutyl, 4-butoxybutyl, 5-butoxypentyl or the like, alkylthioalkyl of 2-10 (preferably 2-6) carbon atoms, such as methylthiomethyl, ethylthiomethyl, propylthiomethyl, 2-methylthioethyl, 2-ethylthioethyl, 2-propylthioethyl, 3-methylthiopropyl, 3-ethylthiopropyl, 3-propylthiopropyl, 4-methylthiobutyl, 4-ethylthiobutyl, 4-butylthiobutyl, 5-butylthiopentyl or the like, aralkyl of 7- 15 (preferably 7-10) carbon atoms, such as benzyl, phenethyl, 3-phenylpropyl, or the like; C.sub.3 -C.sub.10 cycloalkyl, such as cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl, cyclooctyl, cyclononyl, cyclodecyl or the like, or C.sub.4 -C.sub.10 cycloalkylalkyl, such as cyclopropylmethyl, cyclopentylmethyl, cyclohexylmethyl, 2-cyclohexylethyl, cyclooctylmethyl or the like; R.sub.3 is C.sub.1 -C.sub.5 alkyl, such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, pentyl or the like; and R.sub.4 is hydrogen, alkyl of 1-10 (preferably 1-6) carbon atoms, such as methyl, ethyl, propyl, butyl, tert-butyl, hexyl, octyl, decyl or the like, C.sub.6 -C.sub.10 aryl such as phenyl or naphthyl, and preferably phenyl, or aralkyl of 7-12 (preferably 7-10) carbon atoms, such as benzyl, phenethyl or the like.
#Suitable illustrations of R.sub.1 in the above formula (I) are 5-methoxy-1-naphthyl, 6-methoxy-2-naphthyl, 7-methoxy-2-naphthyl, 4,6-dimethoxy-2-naphthyl, 7-methoxy-2-naphthyl, 4,6-dimethoxy-2-naphthyl, 6,7-dimethoxy-2-naphthyl and 6,7-diethoxy- 2-naphthyl.
#Suitable R.sub.2 groups in the above formula (I) are propyl, butyl, isobutyl, pentyl, hexyl, octyl, 2-methoxyethyl, 2-ethoxyethyl, 3-methoxypropyl, 2-methylthioethyl, 2-ethylthioethyl, 3-methylthiopropyl, benzyl, phenethyl, 3-phenylpropyl, cyclopropyl, cyclohexyl, cycloheptyl and cyclohexylmethyl.